Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Envoy Medical (COCH) Operating Margin (2022 - 2026)

Envoy Medical's Operating Margin history spans 5 years, with the latest figure at 15279.49% for Q1 2026.

  • On a quarterly basis, Operating Margin fell 417731.0% to 15279.49% in Q1 2026 year-over-year; TTM through Mar 2026 was 9881.2%, a 69252.0% decrease, with the full-year FY2025 number at 9240.66%, down 68244.0% from a year prior.
  • Operating Margin hit 15279.49% in Q1 2026 for Envoy Medical, down from 8513.33% in the prior quarter.
  • Over the last five years, Operating Margin for COCH hit a ceiling of 3150.88% in Q3 2022 and a floor of 15279.49% in Q1 2026.
  • Historically, Operating Margin has averaged 8736.2% across 5 years, with a median of 8277.97% in 2024.
  • Biggest five-year swings in Operating Margin: skyrocketed 745316bps in 2023 and later plummeted -471190bps in 2025.
  • Tracing COCH's Operating Margin over 5 years: stood at 14530.0% in 2022, then skyrocketed by 51bps to 7076.84% in 2023, then tumbled by -53bps to 10830.95% in 2024, then grew by 21bps to 8513.33% in 2025, then tumbled by -79bps to 15279.49% in 2026.
  • Business Quant data shows Operating Margin for COCH at 15279.49% in Q1 2026, 8513.33% in Q4 2025, and 13590.48% in Q3 2025.